Yahoo! Finance: Top Stories

Leerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy Rating

Jun 26, 2025 - 08:30
 0
Leerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy Rating
Read More

Tags:

Previous Article

Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT

Next Article

Craig-Hallum Maintains a Buy Rating on Bit Digital (BTBT)

Related Posts

Carlyle investment boosts insurance brokerage Trucordia's valuation to $5.7 billion

Carlyle investment boosts insurance brokerage Trucordia...

Jun 4, 2025  0

Nvidia, Tesla lead over $250 billion in short seller losses during massive market rally

Nvidia, Tesla lead over $250 billion in short seller lo...

May 22, 2025  0

Morning Bid: An awkward G7

Morning Bid: An awkward G7

May 20, 2025  0